Proteomic Profiling Identifies Haptoglobin as a Potential Serum Biomarker for Steroid-Resistant Nephrotic Syndrome
American Journal of Nephrology, 07/02/2012
Clinical Article
Wen Q et al. – This study provides a novel overview of the difference in serum proteomes of steroid–sensitive nephrotic syndrome and steroid–resistant nephrotic syndrome patients. Serum haptoglobin may be a useful predictive biomarker for steroid therapy efficacy in the treatment of idiopathic nephrotic syndrome.



